State Street
TARO

State Street’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

State Street’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-172,828
Closed -$7.32M – 4418
2024
Q1 		$7.32M Buy
172,828
+9,135
+6% +$385K ﹤0.01% 2753
2023
Q4 		$6.84M Buy
163,693
+3,583
+2% +$132K ﹤0.01% 2786
2023
Q3 		$6.04M Buy
160,110
+584
+0.4% +$21.9K ﹤0.01% 2839
2023
Q2 		$6.05M Buy
159,526
+101,633
+176% +$3.19M ﹤0.01% 2907
2023
Q1 		$1.41M Buy
57,893
+1,000
+2% +$29.2K ﹤0.01% 3436
2022
Q4 		$1.65M Sell
56,893
-1,489
-3% -$44.2K ﹤0.01% 3434
2022
Q3 		$1.75M Buy
58,382
+7,200
+14% +$248K ﹤0.01% 3455
2022
Q2 		$1.85M Buy
51,182
+700
+1% +$26.7K ﹤0.01% 3503
2022
Q1 		$2.18M Sell
50,482
-1,712
-3% -$80K ﹤0.01% 3531
2021
Q4 		$2.62M Buy
52,194
+974
+2% +$54.6K ﹤0.01% 3556
2021
Q3 		$3.26M Buy
51,220
+1,400
+3% +$96.9K ﹤0.01% 3455
2021
Q2 		$3.58M Buy
49,820
+448
+0.9% +$32.9K ﹤0.01% 3386
2021
Q1 		$3.64M Buy
49,372
+11,600
+31% +$881K ﹤0.01% 3185
2020
Q4 		$2.77M Buy
37,772
+30,544
+423% +$1.96M ﹤0.01% 3233
2020
Q3 		$396K Buy
7,228
+909
+14% +$56.6K ﹤0.01% 3597
2020
Q2 		$420K Buy
6,319
+49
+0.8% +$3.29K ﹤0.01% 3559
2020
Q1 		$384K Hold
6,270
– – ﹤0.01% 3496
2019
Q4 		$551K Buy
6,270
+2,446
+64% +$206K ﹤0.01% 3509
2019
Q3 		$289K Hold
3,824
– – ﹤0.01% 3568
2019
Q2 		$327K Sell
3,824
-100
-3% -$9.89K ﹤0.01% 3566
2019
Q1 		$424K Sell
3,924
-400
-9% -$39.8K ﹤0.01% 3465
2018
Q4 		$366K Sell
4,324
-100
-2% -$9.64K ﹤0.01% 3488
2018
Q3 		$435K Buy
+4,424
New +$479K ﹤0.01% 3496
2018
Q2 		– Sell
-2,655
Closed -$264K – 3810
2018
Q1 		$264K Sell
2,655
-3,611
-58% -$366K ﹤0.01% 3523
2017
Q4 		$654K Sell
6,266
-199,537
-97% -$21.9M ﹤0.01% 3419
2017
Q3 		$23.2M Sell
205,803
-2,361
-1% -$257K ﹤0.01% 1931
2017
Q2 		$23.3M Sell
208,164
-3,062
-1% -$346K ﹤0.01% 1874
2017
Q1 		$24.6M Buy
211,226
+5,214
+3% +$577K ﹤0.01% 1786
2016
Q4 		$21.7M Buy
206,012
+6,933
+3% +$726K ﹤0.01% 1838
2016
Q3 		$22M Buy
199,079
+10,257
+5% +$1.36M ﹤0.01% 1714
2016
Q2 		$27.5M Buy
188,822
+93,185
+97% +$13.2M ﹤0.01% 1531
2016
Q1 		$13.7M Buy
95,637
+12,605
+15% +$1.79M ﹤0.01% 1981
2015
Q4 		$12.8M Buy
83,032
+80,529
+3,217% +$11.8M ﹤0.01% 2041
2015
Q3 		$357K Sell
2,503
-122
-5% -$17.1K ﹤0.01% 3390
2015
Q2 		$377K Sell
2,625
-213
-8% -$30.4K ﹤0.01% 3404
2015
Q1 		$400K Sell
2,838
-492
-15% -$75.7K ﹤0.01% 3404
2014
Q4 		$493K Buy
3,330
+251
+8% +$36.9K ﹤0.01% 3392
2014
Q3 		$474K Sell
3,079
-437
-12% -$65.8K ﹤0.01% 3383
2014
Q2 		$494K Sell
3,516
-1,142
-25% -$127K ﹤0.01% 3334
2014
Q1 		$517K Buy
4,658
+555
+14% +$60.4K ﹤0.01% 3357
2013
Q4 		$406K Buy
4,103
+1,066
+35% +$92.5K ﹤0.01% 3383
2013
Q3 		$230K Buy
+3,037
New +$197K ﹤0.01% 3423

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

State Street's TARO Position: Q2 2024 in Review

State Street sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 172,828 shares — an estimated $7.32M sold.

State Street first reported a position in TARO in Q3 2013 and held it in 42 quarters. The position peaked at $27.5M in Q2 2016. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • State Street reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • State Street sold 172,828 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $7.32M.
  • State Street first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 42 quarters.
  • State Street's Taro Pharmaceutical Industries Ltd. position peaked at $27.5M in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.